Global Irreversible Electroporation Ablators Market Insights and Forecast to 2028

Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.
Market Analysis and Insights: Global Irreversible Electroporation Ablators Market
Due to the COVID-19 pandemic, the global Irreversible Electroporation Ablators market size is estimated to be worth US$ 29 million in 2022 and is forecast to a readjusted size of US$ 48 million by 2028 with a CAGR of 9.1% during the review period. Fully considering the economic change by this health crisis, Generator accounting for % of the Irreversible Electroporation Ablators global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Liver segment is altered to an % CAGR throughout this forecast period.
The world's leading manufacturers of irreversible electroporation ablators are AngioDynamics and Pulse Biosciences. North America is the largest consumption place, with a consumption market share nearly 56%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
Global Irreversible Electroporation Ablators Scope and Segment
Irreversible Electroporation Ablators market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Irreversible Electroporation Ablators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Generator
Part
Service
Segment by Application
Liver
Pancreas
Prostate
Others
By Company
AngioDynamics
Pulse Biosciences
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Frequently Asked Questions